We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+24.43%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$13.3B
AUM Growth
-$343M
Cap. Flow
-$2.51B
Cap. Flow %
-18.9%
Top 10 Hldgs %
48.31%
Holding
117
New
19
Increased
28
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$737M
2
SPGI icon
S&P Global
SPGI
+$177M
3
SHW icon
Sherwin-Williams
SHW
+$160M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$145M
5
GG
Goldcorp Inc
GG
+$139M

Top Sells

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$616M
2
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$370M
3
EQIX icon
Equinix
EQIX
+$283M
4
META icon
Meta Platforms (Facebook)
META
+$194M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$193M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 21.38%
3 Communication Services 17.25%
4 Industrials 6.59%
5 Consumer Discretionary 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZEAL
76
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$16.1M 0.12%
948,700
+48,700
+5% +$730K
CLVS
77
DELISTED
Clovis Oncology, Inc.
CLVS
$14.9M 0.11%
600,000
-400,000
-40% -$10M
VSM
78
DELISTED
Versum Materials, Inc.
VSM
$10.6M 0.08%
+210,000
New +$8.36M
NSTG
79
DELISTED
NanoString Technologies, Inc.
NSTG
$9.57M 0.07%
+400,000
New +$9.19M
VOYA icon
80
Voya Financial
VOYA
$8.86B
$9.24M 0.07%
185,000
– –
S
81
DELISTED
Sprint Corporation
S
$8.98M 0.07%
+1,590,000
New +$9.85M
GOSS icon
82
Gossamer Bio
GOSS
$75.6M
$8.19M 0.06%
+377,852
New +$7.88M
NVTA
83
DELISTED
Invitae Corporation
NVTA
$7.03M 0.05%
+300,000
New +$5.29M
LRMR icon
84
Larimar Therapeutics
LRMR
$434M
$4.93M 0.04%
150,000
+2,083
+1% +$107K
PFNX
85
DELISTED
Pfenex Inc.
PFNX
$3.71M 0.03%
600,000
– –
DVAX
86
DELISTED
Dynavax Technologies
DVAX
$3.65M 0.03%
500,000
-1,500,000
-75% -$14.7M
GCVRZ
87
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.07M 0.02%
6,827,805
– –
APTX
88
DELISTED
Aptinyx Inc. Common Stock
APTX
$2.71M 0.02%
670,000
– –
ASMB icon
89
Assembly Biosciences
ASMB
$700M
$1.97M 0.01%
8,333
-20,834
-71% -$5.27M
TBIO
90
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$1.02M 0.01%
100,000
-400,000
-80% -$3.07M
GOL
91
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$189K ﹤0.01%
+14,498
New +$202K
AVA icon
92
Avista
AVA
$3.15B
– –
-62,900
Closed -$2.67M
BUD icon
93
AB InBev
BUD
$155B
– –
-275,843
Closed -$18.2M
CRNX icon
94
Crinetics Pharmaceuticals
CRNX
$8.99B
– –
-95,365
Closed -$2.86M
DELL icon
95
Dell
DELL
$286B
– –
-7,047,678
Closed -$175M
ILPT
96
Industrial Logistics Properties Trust
ILPT
$554M
– –
-610,545
Closed -$12M
SMH icon
97
PUT
VanEck Semiconductor ETF
SMH
$68.6B
– –
-4,300,000
Closed -$188M
TLRY icon
98
Tilray
TLRY
$666M
– –
-247,952
Closed -$162M
VRSK icon
99
Verisk Analytics
VRSK
$24.4B
– –
-1,441,194
Closed -$157M
VTAK icon
100
Catheter Precision
VTAK
$755K
– –
0
– -$305K
1 2 3
4
5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2019 Portfolio in Review

As of Q1 2019, Thomas Steyer held 117 positions worth $13.3B, down 2.5% from $13.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Thomas Steyer withdrew a net $2.51B in Q1 2019, closing 22 positions and reducing 28 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $616M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 21% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Thomas Steyer opened a new position in Celgene Corp worth $795M.

  • Thomas Steyer's largest Q1 2019 buy was Celgene Corp: 8,430,000 shares worth $795M.
  • Thomas Steyer added most to Red Hat Inc in Q1 2019, an estimated $116M increase.
  • Thomas Steyer's biggest Q1 2019 reduction was Equinix, cutting an estimated $283M.
  • Thomas Steyer fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $616M.
  • Thomas Steyer's ten largest holdings make up 48% of its $13.3B portfolio in Q1 2019.
  • Thomas Steyer opened 19 new positions and closed 22 in Q1 2019.
  • Thomas Steyer's portfolio value fell 2.5% quarter-over-quarter to $13.3B.

Based on Farallon Capital Management's 13F filing for Q1 2019, filed 15 May 2019.